27/06/2024
Alexander Agudelo,Daniela Kinkeldey,Sharon Crane,Martín Ré
Mu2uf@ty
Patent applications for pharmaceutical and biotechnology inventions can be complicated and costly. Our panel will discuss best practices for meeting sufficiency of disclosure requirements in various jurisdictions in a cost-efficient manner. We will also consider whether alternative IP protection, such as trade secrets, would be of greater benefit to your client, particularly in view of the competitive landscape and recent eligibility challenges in obtaining patents, particularly around diagnostics.
Access code: Mu2uf@ty
Share: